Facile Preparation of Macromolecular Prodrugs for Hypoxia-Specific Chemotherapy

Hypoxia-activated prodrugs (HAPs) have emerged as important candidates for chemotherapy due to their efficient killing of hypoxic cancer cells. Traditional small molecule agents, such as tirapazami...